Remote binding energy in antibody catalysis: Studies of a catalytically unoptimized specificity pocket

Journal of the American Chemical Society

Volumn 121, Issue 7, 1999, Pages 1434-1443

  Wade, Herschel ^a   Scanlan, Thomas S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HAPTEN;

ANTIGEN BINDING; ARTICLE; BINDING KINETICS; CATALYSIS; ENZYME ACTIVE SITE; MOLECULAR INTERACTION; REACTION ANALYSIS;

EID: 0033599302     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja983017e     Document Type: Article

References (81)

1. Wade, H.; Scanlan, T. S. Annu. Rev. Biophys. Biomol. Struct. 1997, 26, 461-493.
2. Shokat, K. M.; Schultz, P. G. Annu. Rev. Immunol. 1990, 8, 335-363.
3. Benkovic, S. J. Annu. Rev. Biochem. 1992, 61, 29-54.
4. Jencks, W. P. Catalysis in Chemistry and Enzymology; Dover Publications: Mineola, 1969.
5. Jencks, W. P. Cold Spring Harbor Symp. Quant. Biol. 1987, L11, 65-73.
6. Fersht, A. Enzyme Structure and Mechanism, 2nd ed.; W. H. Freeman & Co.: New York, 1985; pp 147-149.
7. Wade, H.; Scanlan, T. S. J. Am. Chem. Soc. 1996, 118, 6510-6511.
8. Guo, J.; Huang, W.; Scanlan, T. S. J. Am. Chem. Soc. 1994, 116, 6062-6069.
9. Zhou, G. W.; Guo, J.; Huang, W.; Fletterick, R. J.; Scanlan, T. S. Science 1994, 265, 1059-1064.
10. Fersht, A. R. Proc. R. Soc. London B 1974, 187, 397-407.
11. Fersht, A. R.; Dingwall, C. Biochemistry 1979, 18, 1245-1249.
12. Page, M. I. Angew. Chem., Int. Ed. Engl. 1977, 16, 449-459.
13. For an example of the design and functional characterization of an antibody binding site that was designed to exhibit broad specificity at the α-substituent of the amino acid substrate see: Tanaka, F., Kinoshita, K., Tanimura, R., Fujii, I. J. Am. Chem. Soc. 1996, 118, 2332-2339. The relaxation of substrate specificity at this position was accomplished by substituting the α-substituent with the linker.
14. Sheehan, J. C.; Yang, D.-D. H. J. Am. Chem. Soc. 1958, 80, 1154-58.
15. Castro, B.; Evin, G.; Claude, S.; Seyer, R. Synthesis 1977, 413.
16. O'Donnell, M. J.; Wojchiechowski, K. Synthesis 1984, 313-315.
17. Chen, F. M. F.; Benoiton, N. L. Synthesis 1979, 709-710.
18. Segel, I. H. Enzyme Kinetics; John Wiley and Sons: New York, 1975; p 957.
19. The substrate corresponding to 1p is 1. The hydrolysis of phenyl acetate, the substrate that corresponds to the phosphonate, 11p, was not catalyzed by 17E8 (data not shown).
20. Ramakrishnan, C.; Ramachandran, G. N. Biophys. J. 1965, 5, 909-933.
21. Ramachandran, G. N.; Sasisekharan, V. Adv. Protein Chem. 1968, 23, 283-437.
22. The substrate 13 was prepared as a 1:1 mixture of the cis and trans isomers whereas 12 was purely trans.
23. Knowles, J. R. J. Theor. Biol. 1965, 9, 213-228.
24. Hedstrom, L.; Farr-Jones, S.; Kettner, C. A.; Rutter, W. J. Biochemistry 1994, 33, 8764-8769.
25. Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. Biochemistry 1989, 28, 7600-7609.
26. Perona, J. J.; Craik, C. S. Protein Sci. 1995, 4, 337-360.
27. Thompson, R. C. Biochemistry 1974, 13, 5495-5501.
28. Gron, H.; Breddam, K. Biochemistry 1992, 31, 8967-8971.
29. Bone, R.; Shenvi, A. B.; Kettner, C. A.; Agard, D. A. Biochemistry 1987, 26, 7609-7614.
30. Jencks, W. P. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 4046-4050.
31. Kraut, J. Annu. Rev. Biochem. 1977, 46, 331-358.
32. Wolfenden, R. Annu. Rev. Biophys. Bioeng. 1976, 5, 271-306.
33. Transition states of biochemical processes; Gandour, R. D., Schowen, R. L., Eds.; Plenum Press: New York, 1978.
34. Dorovska, V. N.; Varfolomeyev, S. D.; Kazanskaya, N. F.; Klyosov, A. A.; Martinek, K. FEBS Lett. 1972, 23, 122-124.
35. Berezin, I. V.; Kazanskaya, N. F.; Klyosov, A. A.; Martinek, K. FEBS Lett. 1971, 15, 125-128.
36. Fersht, A. R.; Dingwall, C. Biochemistry 1979, 18, 1250-1255.
37. Bartlett, P. A.; Marlowe, C. K. Biochemistry 1983, 22, 4618-4624.
38. Bigler, T. L.; Lu, W.; Park, S. J.; Tashiro, M.; Wieczorek, M.; Wynn, R.; Michael Laskowski, J. Protein Sci. 1993, 2, 786-799.
39. Lu, W.; Apostol, I.; Qasim, M. A.; Warne, N.; Wynn, R.; Zhang, W. L.; Anderson, S.; Chiang, Y. W.; Ogin, E.; Rothberg, I.; Ryan, K.; Laskowski, M. J. Mol. Biol. 1997, 266, 441-461.
40. Compton, D. A. C.; Montero, S.; Murphy, W. F. J. Phys. Chem. 1980, 84, 3587-3591.
41. Allinger, N. L.; Yuh, Y. H.; Lii, J.-H. J. Am. Chem. Soc. 1989, 111, 8551-8559.
42. 3), respectively (see refs 40 and 41).
43. Janin, J.; Wodak, S.; Levitt, M.; Maigret, B. J. Mol. Biol. 1978, 125, 357-386.
44. Pickett, S. D.; Sternberg, M. J. E. J. Mol. Biol. 1993, 231, 825-839.
45. Schrauber, H.; Eisenhaber, F.; Argos, P. J. Mol. Biol. 1993, 230, 592-612.
46. However, the energetic cost needed for the antibody to constrain the side chain is not realized with the fixed rotamer mimick (13). This conformer is about 3.5 kcal/mol higher in energy than the staggered, low-energy conformer (see refs 40 and 41). Thus, structurally constraining the side chain should allow for this energy to be expressed in greater transition state stabilization. The decrease in activity (Tables 1 and 3) for 13 compared to 5 is most likely a result of the fact that the eis isomer does not resemble the bound rotamer precisely due to changes in the hybridization at the δ and γ carbons as well as differences in the dihedral angle between 13 and the actual bound rotamer. The alkene side chain is also less hydrophobic (than 5), thus raising the desolvation cost for binding. The fact that 14 was also a substrate suggests that the rotameric requirement is only important for the torsion angle defined by carbons Cb-Ce.
47. The substrates 6 and 11 (and phosphonates 6p and 11p) were not included in the correlations because we believe that these molecules could not be accommodated without changes in pocket structure or binding mode, making the analysis of these compounds ambiguous.
48. Estell, D. A.; Graycar, T. P.; Miller, J. V.; Powers, D. B.; Burnier, J. P.; Ng, P. G.; Wells, J. A. Science 1986, 233, 659.
49. Although hydrophobicity may play a major role, there are other factors that are also expected to be major contributors to substrate and transition state binding including statistical entropic factors and enthalpic contributors from the formation of van der Waals packing interactions. Sneddon, F. S.; Tobias, D. J. Biochemistry 1992, 31, 2842-2846 and Morton, A.; Baase, W. A.; Mathews, B. W. Biochemistry 1995, 34, 8564- 8575.
50. Although hydrophobicity may play a major role, there are other factors that are also expected to be major contributors to substrate and transition state binding including statistical entropic factors and enthalpic contributors from the formation of van der Waals packing interactions. Sneddon, F. S.; Tobias, D. J. Biochemistry 1992, 31, 2842-2846 and Morton, A.; Baase, W. A.; Mathews, B. W. Biochemistry 1995, 34, 8564-8575.
51. Rose, G. D.; Wolfenden, R. Annu. Rev. Biophys. Biomol. Struct. 1993, 22, 381-415.
52. Pace, C. N. In Methods in Enzymology; 1st ed.; Johnson, M. L., Ackers, G. K., Eds.; Academic Press: San Diego, 1995; Vol. 259; p 761.
53. Richards, F. M. Annu. Rev. Biophys. Bioeng. 1977, 6, 151-176.
54. Fersht, A. R.; Shindler, J. S.; Tsui, W.-C. Biochemistry 1980, 19, 5520-5524.
55. Perona, J. J.; Hedstrom, L.; Rutter, W. J.; Fletterick, R. J. Biochemistry 1995, 34, 1489-1499.
56. Bode, W.; Huber, R. Eur. J. Biochem. 1992, 204, 433-451.
57. Stroud, R. M. Am. Sci. 1974, 231, 74-88.
58. Jackson, S. E.; Moracci, M.; elMasry, N.; Johnson, C. M.; Fersht, A. R. Biochemistry 1993, 32, 11259-11269.
59. Otzen, D. E.; Rhiennecker, M.; Fersht, A. R. Biochemistry 1995, 34, 13051-13058.
60. Hedstrom, L.; Szilagyi, L.; Rutter, W. J. Science 1992, 255, 1249-1253.
61. Berti, P. J.; Fearman, C. H.; Storer, A. C. Biochemistry 1991, 30, 1394-1402.
62. Ingles, D. W.; Knowles, J. R. Biochem. J. 1967, 104, 369-377.
63. Ingles, D. W.; Knowles, J. R. Biochem. J. 1968, 108, 561-569.
64. Gron, H.; Meldal, M.; Breddam, K. Biochemistry 1992, 31, 6011-6018.
65. Albery, W. J.; Knowles, J. R. Biochemistry 1976, 15, 5631-5640.
66. Albery, W. J.; Knowles, J. R. Angew. Chem., Int. Ed. Engl. 1977, 16, 285-293.
67. Knowles, J. R.; Albery, W. J. Acc. Chem. Res. 1977, 10, 105-111.
68. Mulvey, R. S.; Fersht, A. R. Biochemistry 1976, 15, 3-249.
69. Fersht, A. R.; Leatherbarrow, R. J.; Wells, T. C. Biochemistry 1987, 26, 6030-6038.
70. Fersht, A. R.; Wells, T. N. C. Protein Eng. 1991, 4, 229-231.
71. Wells, T. N. C.; Fersht, A. R. Biochemistry 1986, 25, 1881-1886.
72. Lerner, R. A.; Benkovic, S. J.; Schultz, P. G. Science 1991, 252, 659-667.
73. Narlikar, G. L.; Herschlag, D. Biochemistry 1998, 37, 9902-9911.
74. Avis, J. M.; Fersht, A. R. Biochemistry 1993, 32, 5321-5326.
75. Whitty, A.; Fierke, C. A.; Jencks, W. P. Biochemistry 1995, 34, 11678-11689.
76. Ferrin, T. E.; Huang, C. C.; Jarvis, L. E.; Langridge, R. J. Mol. Graphics 1988, 6, 13-27.
77. Bash, P. A.; Pattabiraman, N.; Huang, C. C.; Ferrin, T. E.; Langridge, R. Science 1983, 222, 1325-1327.
78. Fujita, T.; Iwasa, J.; Hansch, C. J. Am. Chem. Soc. 1964, 86, 5175-5181.
79. Hansch, C.; Coats, E. J. Pharm. Sci. 1970, 59, 731-743.
80. Huang, C. C.; Petersen, E. F.; Klein, T. E.; Ferrin, T. E., Langridge, R. J. Mol. Graphics 1991, 9, 230-236.
81. Bevington, P. R.; Robinson, D. K. Data Reduction and Error Analysis for the Physical Sciences, 2nd ed.; McGraw-Hill: New York, 1992; p 328.